Expression of PD-L1, AR, and P53 in urothelial carcinoma and their correlation with clinical prognosis

Expression of PD-L1, AR, and P53 in urothelial carcinoma and their correlation with clinical prognosis

Objective This study aims to observe the expression of programmed cell death 1 ligand 1 (PD-L1), P53, and androgen receptor (AR) in tumor tissues of patients with urothelial carcinoma (UC) and analyze their correlation with patient prognosis. Methods A retrospective analysis was conducted on 115 UC...

Full description

Saved in:

Bibliographic Details
Main Author:	ZHOU Xiaodie, Qi Rongxin, WANG Xuan, YU Bo, WANG Jianjun, SHI Qunli, RAO Qiu, BAO Wei
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Diagnostics Concepts & Practice 2025-06-01
Series:	Zhenduanxue lilun yu shijian
Subjects:	\|urothelial carcinoma\|clinicopathology\|programmed cell death 1 ligand 1\|androgen receptor\|prognosis
Online Access:	https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1756094091985-350834633.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PD-L1 on Circulating Tumor Cells Indicates Poor Prognosis in Breast Cancer
by: Xue-fei Wang, et al.
Published: (2022-11-01)

Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study
by: Junjie Bai, et al.
Published: (2025-07-01)

Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma
by: Yu-Yun Shao, et al.
Published: (2025-04-01)

Cancer cell membrane cloaking nanoparticles for targeted co-delivery of doxorubicin and PD-L1 siRNA
by: Mushi Chen, et al.
Published: (2019-12-01)

Clinical characteristics and comparative analysis of PD-1/PD-L1 inhibitor-induced pituitary dysfunction versus other pituitary disorders
by: Yan Xiao, et al.
Published: (2025-07-01)

Risk scoring model for lung adenocarcinoma based on PD-L1 related signature reveals prognostic predictability and correlation with tumor immune microenvironment genes was constructed
by: Meng Li-Fei, et al.
Published: (2025-06-01)

Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer
by: Neele Wüstmann, et al.
Published: (2023-04-01)

Influence of programmed death ligand 1 (PD-L1) knockout on gut microbiota in experimental autoimmune uveitis
by: Junxiang Gu, et al.
Published: (2025-05-01)

Accessing utility of immunohistochemistry, PD-L1 correlation with stage of cancer and EGFR mutation with disease survival in primary lung carcinoma
by: Kartavya Kumar Verma, et al.
Published: (2025-06-01)

Sulfafurazole dimers potentiate chemo-immunotherapy of low immunogenic breast cancer by preventing the PD-L1 exosomes secretion
by: Zheng Wang, et al.
Published: (2025-05-01)

Development and Validation of a Biolayer Interferometry Method for Determination of Human Anti-PD-1 Monoclonal Antibody Concentration in Cynomolgus Serum
by: K. V. Ulyanova, et al.
Published: (2020-12-01)

Nevi, dysplastic nevi, and melanoma: Molecular and immune mechanisms involving the progression
by: Wei-Wen Sung, et al.
Published: (2022-01-01)

Transformation from prostate adenocarcinoma to high-grade invasive urothelial carcinoma: A case report
by: Dihao Lv, et al.
Published: (2025-08-01)

BAIAP2 as a driver of tumor progression in urothelial bladder cancer
by: Long Huang, et al.
Published: (2025-07-01)

Pediatric papillary urothelial neoplasm: 18-year single-center experience in diagnosis and treatment
by: Pei Liu, et al.
Published: (2025-06-01)

Sarcopenia in Urothelial Bladder Carcinoma: A Narrative Review
by: Constantin Radu Vrabie, et al.
Published: (2025-07-01)

The features of PD-L1 expression in tumor stromal cells, peritumoral microvessels and isolated clusters of tumor cells in breast cancer tissue and their correlation with clinical and morphological characteristics of breast cancer
by: E. Yu. Zubareva, et al.
Published: (2023-11-01)

Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study
by: Junya Arima, et al.
Published: (2025-08-01)

Screening of methylation-related genes and construction of prognostic model in bladder urothelial carcinoma
by: LU Huiru, et al.
Published: (2025-03-01)

Transcriptional, growth factors, components of the AKT/mTOR signaling pathway, receptors and ligands of programmed cell death expression in melanoma
by: K. V. Nikulnikov, et al.
Published: (2024-04-01)

CLINICAL CASE OF TREATMENT OF INVASIVE UROTHELIAL CANCER OF THE UPPER URINARY TRACT. PROBLEMS OF COMBINED TREATMENT
by: A. A. Klimenko, et al.
Published: (2018-03-01)

Aggressive high-grade urothelial carcinoma transforming into enteric-type adenocarcinoma: a case report
by: Vaishnavi Dongare, MSc, et al.
Published: (2025-10-01)

A Case of Secondary Extramammary Paget's Disease Surrounding a Cutaneous Ureterostoma After Recurrence of Bladder Urothelial Carcinoma
by: Masahiro Mizoguchi, et al.
Published: (2025-05-01)

p53/PD-L1 co-expression predicts poor prognosis in diffuse large B-cell lymphoma
by: Yaoyao Jing, et al.
Published: (2025-07-01)

Should follow-up cystoscopy be performed in upper-tract urothelial carcinoma patients managed with radical nephroureterectomy after a five-year bladder tumor-free period?
by: Guoli Wang, et al.
Published: (2025-06-01)

Clinical and Genomic Landscape of FGFR3 Alterations Across Different Stages of Urothelial Cancer
by: Maximilian Haas, et al.
Published: (2025-07-01)

Immunohistochemical Expression of p53 in Epithelial Ovarian Carcinoma and Its Correlation with Clinicopathological Parameters
by: Farzana Sharmin, et al.

Comparison of programmed death ligand-1 expression in preoperative transbronchial lung biopsy and resected specimens in non-small cell lung cancer
by: Naoko Shigeta, et al.
Published: (2025-04-01)

Immune checkpoint inhibitors in patients with advanced gastric cancer: a multi-institutional retrospective real-world study
by: Anastasia Rays, et al.
Published: (2025-03-01)

Phosphoglycerate kinase 1 as a potential prognostic biomarker in papillary thyroid carcinoma
by: Xiao-Qing Shi, et al.
Published: (2025-07-01)

Development and validation of a prediction model for early recurrence in upper tract urothelial carcinoma treated with radical nephroureterectomy
by: Yi-Ju Chou, et al.
Published: (2025-04-01)

MTAP deficiency is highly homogeneous in advanced, muscle-invasive urothelial carcinoma of the urinary bladder
by: Natalia Gorbokon, et al.
Published: (2025-07-01)

Immune Checkpoint Inhibitors in Urothelial Carcinoma (Literature Review)
by: K. V. Menshikov, et al.
Published: (2022-10-01)

Uncommon Urinary Actinomycosis Mimicking Upper Urinary Tract Urothelial Tumor: Case Report and Literature Review
by: Patricia A. Meza-Meneses, et al.
Published: (2025-04-01)

Upper tract urothelial carcinoma in crossed fused renal ectopia: Case report and review of the literature
by: Xiaoxuan Bai, et al.
Published: (2025-09-01)

Cytoreductive nephroureterectomy for treatment of upper urinary tract urothelial carcinoma initially diagnosed as node-positive
by: Shu-Yu Wu, et al.
Published: (2025-08-01)

Evodiamine Boosts AR Expression to Trigger Senescence and Halt Proliferation in OSCC Cells
by: Gang Chen, et al.
Published: (2025-07-01)

Relationship between expression of CEP55 in colorectal cancer tissues and clinicopathological characteristics and prognosis
by: Chen Weili, et al.
Published: (2024-04-01)

Clinicopathological characteristics of transcription factor-defined subtypes in bladder small cell carcinoma
by: Keiichiro Kitahama, et al.
Published: (2025-04-01)

Case Report: Long-term response control in a patient with metastatic gastric squamous cell carcinoma treated with nivolumab and chemoradiotherapy
by: Yu-ying Lei, et al.
Published: (2025-08-01)